Relmada Therapeutics Inc. (RLMD)

RLMD trades at $0.61, 22.0% above the near-term max pain of $0.5 expiring Sep 19, 2025 (28 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is falling across expirations ($0.5-$7.5), signaling increased put positioning or downside protection. Key magnetic zone at 1 where 3 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.

Max pain for RLMD shows a downward trend from 7.5 to 0.5, indicating bearish sentiment or hedging activity. The 304% spread signals divergent expectations across timeframes. Levels distributed around 0.61. Strong magnetic level at 1 (3 expirations). Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.